Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy
| Image |  |
|---|---|
| Description | scientific article published on 23 September 2020 |
| Author/s |
author: Satoshi Fujii |
| Publication date | September 23, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |